[HTML][HTML] A comprehensive systematic review and network meta-analysis: the role of anti-angiogenic agents in advanced epithelial ovarian cancer

AE Helali, CHL Wong, HCW Choi, WWL Chan… - Scientific Reports, 2022 - nature.com
The efficacy of anti-angiogenic agents (AAAs) in epithelial ovarian cancer (EOC) remains
unclear. Therefore, we conducted a systematic review and network meta-analysis (NMA) to …

A Comprehensive Systematic Review and Network Meta-analysis: The Role of anti-angiogenic agents in advanced epithelial ovarian cancer

A El Helali, CHL Wong, HCW Choi, WWL Chan… - 2021 - researchsquare.com
Background The efficacy of anti-angiogenic agents (AAAs) in epithelial ovarian cancer
(EOC) remains unclear. Therefore, we conducted a systematic review and network meta …

A comprehensive systematic review and network meta-analysis: the role of anti-angiogenic agents in advanced epithelial ovarian cancer.

AE Helali, CHL Wong, HCW Choi, WWL Chan… - Scientific …, 2022 - europepmc.org
The efficacy of anti-angiogenic agents (AAAs) in epithelial ovarian cancer (EOC) remains
unclear. Therefore, we conducted a systematic review and network meta-analysis (NMA) to …

[PDF][PDF] A comprehensive systematic review and network meta‑analysis: the role of anti‑angiogenic agents in advanced epithelial ovarian cancer

N Dickson, SWK Siu, KK Chan, HYS Ngan… - Scientific …, 2022 - pureadmin.qub.ac.uk
Method We performed a systematic review and NMA of the curated literature according to
the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) …

A comprehensive systematic review and network meta-analysis: the role of anti-angiogenic agents in advanced epithelial ovarian cancer

AE Helali, CHL Wong, HCW Choi… - Scientific …, 2022 - ui.adsabs.harvard.edu
The efficacy of anti-angiogenic agents (AAAs) in epithelial ovarian cancer (EOC) remains
unclear. Therefore, we conducted a systematic review and network meta-analysis (NMA) to …

[PDF][PDF] A Comprehensive Systematic Review and Network Meta-analysis: The Role of anti-angiogenic agents in advanced epithelial ovarian cancer

A El Helali, CHL Wong, HCW Choi, WWL Chan… - scholar.archive.org
Background The e cacy of anti-angiogenic agents (AAAs) in epithelial ovarian cancer (EOC)
remains unclear. Therefore, we conducted a systematic review and network meta-analysis …

[HTML][HTML] A comprehensive systematic review and network meta-analysis: the role of anti-angiogenic agents in advanced epithelial ovarian cancer

A El Helali, CHL Wong, HCW Choi, WWL Chan… - Scientific …, 2022 - ncbi.nlm.nih.gov
The efficacy of anti-angiogenic agents (AAAs) in epithelial ovarian cancer (EOC) remains
unclear. Therefore, we conducted a systematic review and network meta-analysis (NMA) to …

A comprehensive systematic review and network meta-analysis: the role of anti-angiogenic agents in advanced epithelial ovarian cancer

A El Helali, CHL Wong, HCW Choi… - Scientific …, 2022 - pubmed.ncbi.nlm.nih.gov
The efficacy of anti-angiogenic agents (AAAs) in epithelial ovarian cancer (EOC) remains
unclear. Therefore, we conducted a systematic review and network meta-analysis (NMA) to …

A comprehensive systematic review and network meta-analysis: the role of anti-angiogenic agents in advanced epithelial ovarian cancer

A El Helali, HCW Choi, WWL Chan, N Dickson… - Scientific …, 2022 - pure.qub.ac.uk
The efficacy of anti-angiogenic agents (AAAs) in epithelial ovarian cancer (EOC) remains
unclear. Therefore, we conducted a systematic review and network meta-analysis (NMA) to …

[引用][C] A comprehensive systematic review and network meta-analysis: the role of anti-angiogenic agents in advanced epithelial ovarian cancer

A El Helali, HLC Wong, CW Choi, WLW Chan… - Scientific Reports, 2022 - hub.hku.hk
HKU Scholars Hub: A comprehensive systematic review and network meta-analysis: the role of
anti-angiogenic agents in advanced epithelial ovarian cancer Skip navigation HKU Login Guest …